Susan Hershenson of Amgen is announced as the chair of the forthcoming Protein and Peptide Formulation Conference to be held in Boston, USA
Conference chair announced Susan Hershenson of Amgen is announced as the chair of thre forthcoming Protein and Peptide Formulation Conference to be held in Boston, USA.
Susan Hershenson, senior director in the pharmaceutics department at Amgen will chair IIR's Protein and Peptide Formulation Strategies For Drug Development and Delivery conference 31 March - 2 April 2003 at the Swissotel in Boston, USA.
Registration is well under way and it looks to be an outstanding event.
By bringing together the leading researchers from academia and industry IIR's Protein and Peptide Formulation Strategies for Drug Development and Delivery conference helps you find solutions for the most challenging aspects of protein and peptide formulation and drug delivery.
This gathering of protein and peptide formulation experts presents an opportunity to gain exposure to companies and industry experts leading the path toward selecting the most appropriate formulation for a protein or peptide drug in terms of efficient development, costeffectiveness, patient compliance, and safety.
The conference features a highly distinguished and diverse faculty, including: Susan Hershenson, Amgen, conference chair.
Byeong Chang, Amgen.
Panayiotis P Constantinides, Oradel Systems/Dor Biopharma.
Sean A Evans, Syntonix Pharmaceuticals. Stephen Farr, Aradigm.
Hamid Ghandehari, Univeristy of Maryland school of pharmacy.
Isabel Gomez-Orellana,Emisphere Technolgies. Patrick R Griffin, Exsar.
Lakshmi Khandke, Wyeth Vaccines.
Kam Leong, Johns Hopkins University.
Jack M Lipman, Enzon.
Catherine Lucas, Alza.
Tulin Morcol, Biosante Pharmaceuticals.
Steven J Prestrelski, Algorx Technologies.
Li Shi, Merck Research Laboratories.
Christian Schoneich, University of Kansas.
